Our R&D Team

Learn more about the backgrounds, scientific pursuits and personal interests of members of our R&D team. These individuals are committed to pursuing Bristol Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.

Beatrice Anduze-Faris, M.D.

Vice President, Global Clinical Compliance and Continuous Improvement (GCC&CI), Global Development Operations, Central New Jersey

Tunde Bello

Vice President, Clinical Pharmacology and Pharmacometrics, Central New Jersey

Michaela Bowden, Ph.D.

Director, Translational Biology, Cambridge, MA

Cynthia Brogdon, RN, Ph.D.

Head, Oncology Portfolio Strategy, Oncology Medical, Central New Jersey

Miranda Broz, Ph.D.

Scientific Associate Director, Discovery Myeloid Biology, Tumor Microenvironment Thematic Research Center, Redwood City, CA 

Charlotte Chapman

Head, Regional Clinical Operations Business Management, Global Development Operations, London, UK

Edgar Charles, M.D.

Clinical Development Lead, Fibrosis R&D, Central New Jersey

Roland Chen, M.D.

Senior Vice President and Head, Cardiovascular Development, Global Drug Development, Central New Jersey

Sharon Cload, Ph. D.

Vice President, Discovery Biotherapeutics, East Coast, Cambridge, MA

Elizabeth (Liz) Colston, M.D., Ph.D.

Clinical Development Lead, Dermatology, Central New Jersey

Myrtle Davis, DVM, Ph.D.

Executive Director, Discovery Toxicology,  Central New Jersey

Justine Dell’Aringa

Associate Director, Translational Medicine, Immuno-Oncology and Cell Therapy, Seattle, WA

Binodh DeSilva, Ph.D.

Vice President, Lead, Discovery and Optimization, Small Molecule Drug Discovery, Central New Jersey

Teresa (Teri) Foy, Ph.D.

Senior Vice President, Research and Early Development Immuno-Oncology and Cell Therapy, Seattle, WA

David Gordon, Ph.D.

Vice President, Cardiovascular and Fibrosis Discovery Biology, Central New Jersey

Richard Hargreaves, Ph.D.

Senior Vice President, Neuroscience Thematic Research Center, Central New Jersey

Melissa Harris, B.Sc, PharmD

Vice President and Head of Fibrosis Development, Central New Jersey

Kristen M. Hege, M.D.

Senior Vice President, Early Clinical Development, Oncology/Hematology and Cell Therapy, San Francisco, CA

Evan Janovitz, DVM, PH.D., DAVCP

Director, Pathology, Discovery Toxicology , Central New Jersey

Lata Jayaraman, Ph.D.

Head, Oncology Drug Discovery, Cambridge, MA

Debbie Law (DPhil)

Senior Vice President, Head, Tumor Microenvironment Thematic Research Center, Redwood City, California

Emma Lees, Ph.D.

Head, Mechanisms of Cancer Resistance Thematic Research Center, Cambridge, MA

Michael May, Ph.D.

Countrywide Medical Director, Germany, Global Medical

Patty McDonnell, Ph.D.

Senior Director, Enterprise Governance R&D, Central New Jersey

Ryan Moslin, Ph.D.

Principal Scientist, Oncology Chemistry, Central New Jersey

Saumya Pant, Ph.D.

Director, Clinical Genomics and Genetics, Central New Jersey

Robert Plenge, M.D., Ph.D.

Senior Vice President and Head, Immunology, Cardiovascular and Fibrosis Thematic Research Center; Head, Translational Medicine, Cambridge MA

Chetana Rao, Ph.D.

Head, Site Strategy & Operations, Redwood City and San Francisco, CA

Mark Rolfe, Ph.D.

Senior Vice President, Oncogenesis Thematic Research Center, San Francisco, CA

Joseph Szustakowski, Ph.D.

Vice President, Translational Bioinformatics, Informatics and Predictive Sciences, Central New Jersey

John Throup, BSc, Ph.D.

Vice President, Development Program Lead, Dermatology, Central New Jersey